학술논문

SYVN1 modulates papillary thyroid carcinoma progression by destabilizing HMGB1.
Document Type
Article
Source
Cell Division. 4/28/2024, Vol. 19 Issue 1, p1-9. 9p.
Subject
*PAPILLARY carcinoma
*THYROID cancer
*MOLECULAR biology
*BRAF genes
*CELL physiology
*UBIQUITIN ligases
Language
ISSN
1747-1028
Abstract
E3 ubiquitin ligase synoviolin (SYVN1) has been reported to participate in many human cancers. This study aimed to investigate SYVN1's roles and molecular pathways in papillary thyroid cancer (PTC). The functions of SYVN1 in PTC were further analyzed using gain- and loss-of-function methods and numerous investigations in cellular function and molecular biology. The findings demonstrated that the overexpression of SYVN1 markedly suppressed the proliferation, migration, and invasion of PTC cell lines (NPA87 and TPC-1). We found that SYVN1 interacted with HMGB1 and promoted its ubiquitination and degradation. In addition, SYVN1 effectively impairs cell proliferation, migration, invasion, and the formation of tumor xenografts in mice models. However, this effect may be partly reversed by overexpressing HMGB1. Thus, SYVN1 may inhibit the proliferation, migration, and invasion of PTC cells by disrupting HMGB1. Consequently, SYVN1 might be considered a promising therapeutic target for PTC. [ABSTRACT FROM AUTHOR]